| Authors Key Contacts | |
|---|---|
| Issue | May-2026 |
| Practice Areas | |
| Industries | Food and BeverageMedical, Pharmaceutical, Healthcare, Life Science and BiotechnologyChemical |
Newsletter "Life Science Newsletter (May 2026)" has been published.
Contents
1. Amendments to the Health Insurance Act
1.1 Establishment of “Partially Uninsured Medical Treatment” for OTC-Equivalent Drugs
1.2 Other Amendments
1.3 Supplementary Resolution
2. Enforcement of the Amended PMD Act
2.1 Scope
2.2 Conditional Approval
2.3 Points to Note for the Marketing of Conditionally Approved Pharmaceuticals